<p>The ubiquitin E3 ligase SCF<sup>FBXO24</sup> targets key proteins for degradation that regulate important biological processes, but the mechanisms controlling cellular concentrations of its receptor subunit, F-box only protein 24 (FBXO24), remain unknown. Here, <i>Haemophilus influenzae</i> type B (HiB), an important cause of pneumonia, protects FBXO24 from lysosomal degradation in THP-1 macrophage cells by reducing its ubiquitylation levels. We identified that the ubiquitin-specific peptidase 4 (USP4) mediates FBXO24 deubiquitylation and stabilization in response to HiB infection in a TLR4 receptor-dependent manner. In experimental HiB pneumonia, either nanoparticle delivery of encapsulated <i>USP4</i> siRNA or targeted genetic disruption of <i>Fbxo24</i> in mice led to increased alveolar mononuclear cells coupled with reduced bacterial loads, attenuated pulmonary edema and decreased lung injury severity compared to control mice. Collectively, these findings demonstrate&#xa0;the&#xa0;ability of a bacterial pathogen to exploit a deubiquitylation mechanism to preserve cellular levels of an E3 ligase component, thereby impairing innate host defense responses.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The deubiquitinase USP4 stabilizes the SCFFBXO24 ubiquitin E3 ligase to regulate immunity in experimental pneumonia

  • Ilknur Yurtsever,
  • Daniela Farkas,
  • Alex Cornwell,
  • Jessica A. Joseph,
  • Siying Xu,
  • Joshua A. Englert,
  • Joseph S. Bednash,
  • James D. Londino,
  • Benjamin S. Johnson,
  • Rama K. Mallampalli

摘要

The ubiquitin E3 ligase SCFFBXO24 targets key proteins for degradation that regulate important biological processes, but the mechanisms controlling cellular concentrations of its receptor subunit, F-box only protein 24 (FBXO24), remain unknown. Here, Haemophilus influenzae type B (HiB), an important cause of pneumonia, protects FBXO24 from lysosomal degradation in THP-1 macrophage cells by reducing its ubiquitylation levels. We identified that the ubiquitin-specific peptidase 4 (USP4) mediates FBXO24 deubiquitylation and stabilization in response to HiB infection in a TLR4 receptor-dependent manner. In experimental HiB pneumonia, either nanoparticle delivery of encapsulated USP4 siRNA or targeted genetic disruption of Fbxo24 in mice led to increased alveolar mononuclear cells coupled with reduced bacterial loads, attenuated pulmonary edema and decreased lung injury severity compared to control mice. Collectively, these findings demonstrate the ability of a bacterial pathogen to exploit a deubiquitylation mechanism to preserve cellular levels of an E3 ligase component, thereby impairing innate host defense responses.